Hydrogenology
Source-linked study record

Combination of Hydrogen Inhalation and Hypothermic Temperature Control After Out-of-Hospital Cardiac Arrest: A Post hoc Analysis of the Efficacy of Inhaled Hydrogen on Neurologic Outcome Following Brain Ischemia During PostCardiac Arrest Care II Trial

Tamura T, Narumiya H, Homma K, Suzuki M, Efficacy of Inhaled Hydrogen on Neurologic Outcome Following Brain Ischemia During PostCardiac Arrest Care (HYBRID II) Study Group. · Critical care medicine. 2024;52(10):1567-1576.

HumanInhaled H₂Published 2024Source checked
Study record, not medical adviceThis record reports what the source states. It is not medical advice and does not establish that molecular hydrogen is effective, safe or appropriate for any person.
Quick summary

Study at a glance

Evidence type

Human

Population or model

Human participants studied for cardiovascular and circulatory health. See eligibility criteria in the linked full text.

Intervention and dose

Full text reports inhaled H₂-containing gas. Detected intervention quantities or schedules: 2%, 94%, 50%, 18 hours. · H₂-related quantities reported in the intervention passages: 2%, 94%, 50%, 18 hours. Values are not combined across different experimental arms.

Duration

18 hours

Reported result

Article-reported result excerpt (24 words maximum): “The adjusted analysis using the generalized estimating equations model showed that a combination of hydrogen and TTM32–TTM34 was associated with a higher rate of…” This excerpt is not a complete result summary; consult the linked full text for all positive and null findings.

Main limitation

Human evidence; design, sample size and comparator limit interpretation. No funding statement was identified in the machine-readable full article; absence is not inferred. No explicit conflict statement was identified in the machine-readable full article; absence is not inferred.

Evidence and classification

What kind of evidence is this?

Evidence type

Human

Reported design

Randomized controlled study

Research topic

Cardiovascular and circulatory health

Administration form

Inhaled H₂

Information not yet classified

Some editorial classification fields are still pending. The source-reported outcomes and result are shown below; Hydrogenology does not infer a positive or negative signal from prose automatically.

Reported in the source

Methods

Population or model

Human participants studied for cardiovascular and circulatory health. See eligibility criteria in the linked full text.

Sample

Human study; the full text reports 72 participants.

Duration

18 hours

Intervention

Full text reports inhaled H₂-containing gas. Detected intervention quantities or schedules: 2%, 94%, 50%, 18 hours.

Hydrogen form

Inhaled molecular H₂ at 2%; not classified as Brown’s gas without an H₂/O₂ composition.

Dose or H₂ specification

H₂-related quantities reported in the intervention passages: 2%, 94%, 50%, 18 hours. Values are not combined across different experimental arms.

H₂ flow

Not reported in the full article — an absolute H₂ flow in mL/min could not be verified.

O₂ delivered with H₂

O₂ concentration and absolute O₂ flow were not both reported in the full article; no value is inferred.

Comparator

Control or comparison condition reported in the full article; see the linked methods for arm-specific details.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

survival or mortality, clinical symptoms or functional scores, inflammation and cytokines, oxidative-stress and antioxidant markers, apoptosis or cell injury, histology or tissue damage

Reported result

Article-reported result excerpt (24 words maximum): “The adjusted analysis using the generalized estimating equations model showed that a combination of hydrogen and TTM32–TTM34 was associated with a higher rate of…” This excerpt is not a complete result summary; consult the linked full text for all positive and null findings.

Extraction completeness

The complete machine-readable article was checked for source identity, methods, intervention quantities, results, tables, funding and conflict declarations. This public record is based on the full article.

A reported association, difference or mechanism is not automatically a clinical benefit.

Interpretation limits

Limitations and applicability

Main methodological cautions

Human evidence; design, sample size and comparator limit interpretation. No funding statement was identified in the machine-readable full article; absence is not inferred. No explicit conflict statement was identified in the machine-readable full article; absence is not inferred.

Applies directly to

Applies only to the population and protocol reported in this cardiovascular and circulatory health article.

No single-study GRADE certainty rating is assigned. Read how records and evidence assessments are prepared.

Sources and status

Sources and record status

Identifiers

PMID: 39133068 · DOI: 10.1097/ccm.0000000000006395

Publisher access

A free full article is available through PubMed Central.

Extraction basis

Official Europe PMC JATS full article and PubMed/PMC identifiers; structured full-text extraction and validation completed 8 August 2026.

Last reviewed

10 August 2026

Help the next reader

Help people check the facts before they buy.

Hydrogenology keeps 665 source-checked records accessible without advertising or product promotion.

Support independent access
Help us correct the recordReport a discrepancy

Send the exact difference between this page and the linked source. The study reference is attached automatically.